Get the Stockscreener App
36.34
0.33%
-0.12
Quidelortho Corporation stock is traded at $36.34, with a volume of 3.25M.
It is down -0.33% in the last 24 hours and up +25.96% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.
See More
Previous Close:
$36.46
Open:
$36.95
24h Volume:
3.25M
Relative Volume:
2.48
Market Cap:
$1.96B
Revenue:
$2.82B
Net Income/Loss:
$-1.87B
P/E Ratio:
-1.3025
EPS:
-27.9
Net Cash Flow:
$-96.80M
1W Performance:
+24.79%
1M Performance:
+25.96%
6M Performance:
-16.94%
1Y Performance:
-16.69%
1-Day Range:
$35.45
$36.95
1-Week Range:
$25.65
$37.24
52-Week Range:
$23.77
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
Name
Quidelortho Corporation
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
36.34 | 1.96B | 2.82B | -1.87B | -96.80M | -27.90 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-08-25 | Upgrade | Jefferies | Hold → Buy |
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Sep-19-24 | Resumed | UBS | Neutral |
| Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-04-24 | Downgrade | UBS | Neutral → Sell |
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corporation Stock (QDEL) Latest News
Quidelortho sees $30M-$40M tariff impact offset, maintains 2025 guidance - MSN
QuidelOrtho Stock Gains Following Q1 Earnings Beat, Margins Expand - MSN
QuidelOrtho First Quarter 2025 Earnings: EPS Beats Expectations - simplywall.st
Jefferies upgrades QuidelOrtho to Buy, says ‘no news is good news’ - TipRanks
10 Unexpected Market Movers – What Propelled Double-Digit Gains? - Insider Monkey
Why QuidelOrtho Corporation (QDEL) Went Up On Thursday - Yahoo
QuidelOrtho Earnings Call: Growth Amid Challenges - TipRanks
Jefferies Upgrades QuidelOrtho (QDEL) - Nasdaq
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationQDEL - ACCESS Newswire
UBS Maintains Neutral Rating for QuidelOrtho (QDEL), Lowers Price Target | QDEL Stock News - GuruFocus
Why Is QuidelOrtho (QDEL) Stock Soaring Today - Yahoo Finance
Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
QuidelOrtho (QDEL) Upgraded to Buy by Jefferies | QDEL Stock News - GuruFocus
QuidelOrtho Shares Gain After Q1 Adjusted Earnings Beat Consensus - marketscreener.com
Jefferies Elevates QuidelOrtho (QDEL) to Buy Rating Amid Positive Outlook | QDEL Stock News - GuruFocus
UBS Reduces Price Target for QuidelOrtho (QDEL) to $29 | QDEL Stock News - GuruFocus
UBS Cuts Price Target on QuidelOrtho to $29 From $45, Keeps Neutral Rating - marketscreener.com
QuidelOrtho Corporation (NASDAQ:QDEL) Q1 2025 Earnings Call Transcript - Insider Monkey
QuidelOrtho revenue increases 5% to USD 693M in Q1 2025 - Medical Buyer
QuidelOrtho's Q1 CY2025 Financial Performance: Revenue Decline and Profit GrowthNews and Statistics - IndexBox
QuidelOrtho Q1 Adjusted Earnings Rise, Revenue Falls; Fiscal 2025 Guidance Maintained - marketscreener.com
QuidelOrtho Corp (QDEL) Q1 2025 Earnings Call Highlights: Strong Growth in Core Segments Amid ... - Yahoo Finance
QuidelOrtho Corp (QDEL) Q1 2025 Earnings Call Highlights: Strong Growth in Core Segments Amid Revenue Decline - GuruFocus
QuidelOrtho: Q1 Earnings Snapshot - Norwalk Hour
QuidelOrtho Reports Strong Q1 2025 Financial Results - TipRanks
QuidelOrtho Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: QuidelOrtho Q1 2025 beats EPS, stock up 7.5% - Investing.com Australia
QuidelOrtho Q1 2025 presentation slides: EPS surges 68% despite flat revenue - Investing.com
QDEL Confident in Minimizing Tariff Impacts | QDEL Stock News - GuruFocus
QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Reports Q1 In Line With Expectations, Stock Soars - Yahoo
QuidelOrtho sees FY25 Labs business growth in mid-single digits - TipRanks
Quidel shares surge 7.8% as Q1 earnings beat estimates By Investing.com - Investing.com Nigeria
QuidelOrtho (QDEL) Projects Steady Growth Across Key Segments for 2025 | QDEL Stock News - GuruFocus
Quidel shares surge 7.8% as Q1 earnings beat estimates - Investing.com Australia
QuidelOrtho (QDEL) Exceeds Q1 Revenue Expectations | QDEL Stock News - GuruFocus
QuidelOrtho Corp Q1 2025 Earnings: Adjusted EPS of $0.74 Beats Estimates, Revenue Hits $693 Million Surpassing Projections - GuruFocus
(QDEL) QUIDELORTHO CORPORATION Sees Q2 Adjusted EPS Range $2.07$2.57 - marketscreener.com
QuidelOrtho Reports First Quarter 2025 Financial Results - Stock Titan
QuidelOrtho (QDEL) Earnings Expected to Grow: Should You Buy? - MSN
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN - TradingView
QuidelOrtho Earnings: What To Look For From QDEL - Yahoo Finance
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL)June 11, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Reminds QuidelOrtho Corporation f/k/a Quidel Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024QDEL - ACCESS Newswire
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) should contact Levi & Korsinsky about pending Class ActionQDEL - ACCESS Newswire
4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates - TradingView
QuidelOrtho Corporation (QDEL): Among Billionaire David Harding’s Stock Picks with Huge Upside Potential - Insider Monkey
Press Release Distribution & PR Platform - ACCESS Newswire
Why QuidelOrtho (QDEL) Could Beat Earnings Estimates Again - MSN
Quidelortho Corporation Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quidelortho Corporation Stock (QDEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Blaser Brian J. | President and CEO |
Dec 11 '24 |
Buy |
41.42 |
6,033 |
249,878 |
6,033 |
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):